Breaking Down Ultragenyx Pharmaceutical: 4 Analysts Share Their Views
11/7 00:00
Ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over......